Prospective Comparative Study of Etoposide plus G-CSF versus G-CSF Alone, Followed by Risk-Adapted Plerixafor for Peripheral Blood Stem Cell Mobilization in Patients with Newly Diagnosed Multiple Myeloma: CAtholic REsearch Network for Multiple Myeloma Study (CAREMM-2001).

Park, Sung-Soo; Shin, Seung-Hwan; Lee, Jung-Yeon; Jeon, Young-Woo; Yhang, Seung-Ah; Min, Chang-Ki

Park, Sung-Soo; Shin, Seung-Hwan; Lee, Jung-Yeon; Jeon, Young-Woo; Yhang, Seung-Ah; Min, Chang-Ki.

Afiliação

Park SS; Hematology Hospital, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul 02706, Republic of Korea.
Shin SH; Myeoma Center, Hematology Institute, Eunpyeong St. Mary's Hospital, The Catholic University of Korea, Seoul 03312, Republic of Korea.
Lee JY; Hematology Hospital, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul 02706, Republic of Korea.
Jeon YW; Department of Hematology, Yeouido St. Mary's Hospital, The Catholic University of Korea, Seoul 07345, Republic of Korea.
Yhang SA; Department of Hematology, Incheon St. Mary's Hospital, The Catholic University of Korea, Incheon 21431, Republic of Korea.
Min CK; Hematology Hospital, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul 02706, Republic of Korea.

Cancers (Basel) ; 15(19)2023 Sep 28.

Article em En | MEDLINE | ID: mdl-37835477